Morgan Stanley Ocugen, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Ocugen, Inc. stock. As of the latest transaction made, Morgan Stanley holds 961,427 shares of OCGN stock, worth $817,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares

961,427

Previous 627,659 53.18%

Holding current value

$817,212

Previous $972,000 2.16%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.98 - $1.95 $327,092 - $650,847	333,768 Added 53.18%	961,427 $951,000
Q2 2024 Oct 17, 2024	BUY	$1.18 - $1.98 $9,739 - $16,342	8,254 Added 1.33%	627,659 $972,000
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.98 $9,739 - $16,342	8,254 Added 1.33%	627,659 $972,000
Q1 2024 Oct 17, 2024	SELL	$0.5 - $1.83 $4,127 - $15,104	-8,254 Reduced 1.32%	619,405 $1.02 Million
Q1 2024 Aug 16, 2024	BUY	$0.5 - $1.83 $161,618 - $591,521	323,236 Added 109.14%	619,405 $1.02 Million
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $161,618 - $591,521	323,236 Added 109.14%	619,405 $1.02 Million
Q4 2023 Aug 16, 2024	SELL	$0.36 - $0.57 $119,336 - $188,949	-331,490 Reduced 52.81%	296,169 $168,000
Q4 2023 Feb 13, 2024	BUY	$0.36 - $0.57 $5,525 - $8,748	15,348 Added 5.47%	296,169 $168,000
Q3 2023 Nov 15, 2023	SELL	$0.4 - $0.62 $27,517 - $42,651	-68,793 Reduced 19.68%	280,821 $112,000
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.88 $21,674 - $42,386	-48,166 Reduced 12.11%	349,614 $188,000
Q1 2023 May 15, 2023	SELL	$0.82 - $1.33 $40,111 - $65,059	-48,917 Reduced 10.95%	397,780 $338,000
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.87 $25,988 - $43,782	23,413 Added 5.53%	446,697 $580,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $3.66 Million - $6.49 Million	-2,092,933 Reduced 83.18%	423,284 $753,000
Q2 2022 Oct 27, 2022	BUY	$1.83 - $3.45 $907,753 - $1.71 Million	496,040 Added 24.55%	2,516,217 $5.71 Million
Q2 2022 Aug 15, 2022	BUY	$1.83 - $3.45 $907,753 - $1.71 Million	496,040 Added 24.55%	2,516,217 $5.71 Million
Q1 2022 Oct 27, 2022	SELL	$2.34 - $4.72 $1.16 Million - $2.34 Million	-496,040 Reduced 19.71%	2,020,177 $6.67 Million
Q1 2022 May 13, 2022	BUY	$2.34 - $4.72 $3.31 Million - $6.68 Million	1,414,556 Added 233.57%	2,020,177 $6.67 Million
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $150,943 - $540,019	-34,462 Reduced 5.38%	605,621 $2.76 Million
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $4.07 Million - $5.45 Million	640,083 New	640,083 $4.6 Million

Others Institutions Holding OCGN

# of Institutions

124

Shares Held

78.3M

Call Options Held

535K

Put Options Held

523K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $184M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account